Ben Attwood

Ben Attwood

Auto-generated profile, based on publicly available information

Ben Attwood

Department of Anaesthesia and Intensive Care, South Warwickshire NHS Foundation Trust, Warwick CV34 5BW, UK

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in Intensive and Critical Care Nursing
Verified
Journal Article
Closed access
DMDavid McWilliams
David McWilliams
CSCatherine Snelson
Catherine Snelson
HGHannah Goddard
Hannah Goddard
BABen Attwood
Ben Attwood

24 December 2015 in Obstetric Medicine
Verified
Journal Article
Open access
PDF file
CFCharlotte J Frise
Charlotte J Frise
BABen Attwood
Ben Attwood
PWPeter Watkinson
Peter Watkinson
LMLucy Mackillop
Lucy Mackillop
Pregnancy is an insulin resistant state. Hyperglycaemia and gestational diabetes mellitus are well-recognised complications even in women without existing metabolic syndrome or obesity. Pregnant women also appear to be more vulnerable to ketoacidosis, particularly after short periods of reduced oral intake in the third trimester, and may present with very severe starvation ketoacidosis, prompting emergent delivery. We present a case of a woman with a background of depression and psychotic episodes. Olanzapine had been commenced after a psychotic episode at 20 weeks’ gestation. Gestational diabetes mellitus was diagnosed at 28 weeks, and she was then admitted at 31 weeks with severe euglycaemic ketoacidosis following a short period of vomiting. She underwent caesarean section when the metabolic disturbances did not resolve with medical treatment. We believe atypical antipsychotic therapy contributed to the profound insulin resistance seen here, and that obstetricians, physicians and psychiatrists must be aware of the risks conferred by these agents in pregnancy.

1 November 2011 in Journal of Ultrasound in Medicine
Verified
Journal Article
Open access
PDF file
ALAndrew S. Liteplo
Andrew S. Liteplo
VNVicki E. Noble
Vicki E. Noble
BABen H. C. Attwood
Ben H. C. Attwood
RMRdms Andrew S. Liteplo Md
Rdms Andrew S. Liteplo Md
BMBchir Ben H. C. Attwood Mb
Bchir Ben H. C. Attwood Mb
Objectives As the use of point‐of‐care sonography spreads, so too does the need for remote expert over‐reading via telesonogrpahy. We sought to assess the feasibility of using familiar, widespread, and cost‐effective existent technology to allow remote over‐reading of sonograms in real time and to compare 4 different methods of transmission and communication for both the feasibility of transmission and image quality. Methods Sonographic video clips were transmitted using 2 different connections (WiFi and 3G) and via 2 different videoconferencing modalities (iChat [Apple Inc, Cupertino, CA] and Skype [Skype Software Sàrl, Luxembourg]), for a total of 4 different permutations. The clips were received at a remote location and recorded and then scored by expert reviewers for image quality, resolution, and detail. Results Wireless transmission of sonographic clips was feasible in all cases when WiFi was used and when Skype was used over a 3G connection. Images transmitted via a WiFi connection were statistically superior to those transmitted via 3G in all parameters of quality (average P = .031), and those sent by iChat were superior to those sent by Skype but not statistically so (average P = .057). Conclusions Wireless transmission of sonographic video clips using inexpensive hardware, free videoconferencing software, and domestic Internet networks is feasible with retention of image quality sufficient for interpretation. WiFi transmission results in greater image quality than transmission by a 3G network.

28 September 2017 in Journal of the Intensive Care Society
Verified
Journal Article
Open access
GRGeorge Reid
George Reid
JBJonathan Bedford
Jonathan Bedford
BABen Attwood
Ben Attwood
Point-of-care ultrasound is increasingly recognised as a valuable adjunct to patient care. Trainees in intensive care medicine are expected to accredit in focused intensive care echocardiography, but the availability of trained mentors and logistical/geographical factors make this difficult within the time constraints required. As a result, many trainees who are enthusiastic about point-of-care ultrasound find it difficult to achieve accreditation. We present a secure, web-based, multi-user system which mitigates many of these difficulties and allows for clinical mentorship to take place without geographical barriers, and at a time convenient for the participants.

15 August 2007 in British Journal of Clinical Pharmacology
Verified
Journal Article
Open access
PDF file
DCD. Ross Camidge
D. Ross Camidge
JOJames J. Oliver
James J. Oliver
CSCarolyn Skinner
Carolyn Skinner
BABen Attwood
Ben Attwood
FNFiona Nussey
Fiona Nussey
DWDavid J. Webb
David J. Webb
What is already known about this subject • The dominant health economic units upon which new treatment funding decisions are made are the incremental cost per life year gained (LYG) or the cost per quality‐adjusted life year (QALY) gained. • Neither of these units modifies the amount of health gained, by the amount of health patients would have had if they had not been given the treatment under consideration, which may unfairly undervalue the treatments for poor prognosis conditions. • How certain patients make decisions about their own treatment has previously been explored, but not how they, or doctors, would allocate hypothetical resource within a healthcare system given information on disease‐treatment scenarios' prognoses with and without treatment. What this study adds • Information on prognosis without treatment is used within the resource allocation strategies of many doctors and most patients. • Individuals use this information in a variety of different ways and a single dominant strategy for quantitative modification of health units is not apparent. • Information on prognosis without treatment, or prognosis with standard treatment, is available from the control arm of randomized controlled clinical trials and should be used qualitatively to facilitate decision‐making around the second inflexion point on cost per QALY/LYG acceptability curves. Aims Health economic assessments increasingly contribute to funding decisions on new treatments. Treatments for many poor prognosis conditions perform badly in such assessments because of high costs and modest effects on survival. We aimed to determine whether underlying shortness of prognosis should also be considered as a modifier in such assessments. Methods Two hundred and eighty‐three doctors and 201 oncology patients were asked to allocate treatment resource between hypothetical patients with unspecified life‐shortening diseases. The prognoses with and without treatment were varied such that consistent use of one of four potential allocation strategies could be deduced: life years gained (LYGs) – which did not incorporate prognosis without treatment information; percentage increase in life years (PILY); life expectancy with treatment (LEWT) or immediate risk of death (IRD). Results Random choices were rare; 47% and 64% of doctors and patients, respectively, used prognosis without treatment in their strategies; while 50% and 32%, respectively, used pure LYG‐based strategies. Ranking orders were LYG > PILY > IRD > LEWT (doctors) and LEWT > LYG > IRD > PILY (patients). When LYG information alone could not be used, 76% of doctors prioritized shorter prognoses, compared with 45% of patients. Conclusions Information on prognosis without treatment is used within the resource allocation strategies of many doctors and most patients, and should be considered as a qualitative modifier during the health economic assessments of new treatments for life‐shortening diseases. A single dominant strategy incorporating this information for any quantitative modification of health units is not apparent.

11 March 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
JCJohn P Corcoran
John P Corcoran
MHMark Hew
Mark Hew
BABen Attwood
Ben Attwood
MSMurali Shyamsundar
Murali Shyamsundar
SSSheera Sutherland
Sheera Sutherland
NRNajib Rahman
Najib Rahman
Background: Lung ultrasound (LUS) is increasingly used as an extension of physical examination, informing clinical diagnosis, and decision making. There is particular interest in the assessment of patients with pulmonary congestion and extravascular lung water, although gaps remain in the evidence base underpinning this practice as a result of the limited evaluation of its inter-rater reliability and comparison with more established radiologic tests. Methods: 30 patients undergoing haemodialysis were prospectively recruited to an observational cohort study (NCT01949402). Patients underwent standardised LUS assessment before, during and after haemodialysis; their total LUS B-line score was generated, alongside a binary label of whether appearances were consistent with an interstitial syndrome. LUS video clips were recorded and independently scored by two blinded expert clinician sonographers. Low-dose non-contrast thoracic CT, pre- and post dialysis, was used as a “gold standard” radiologic comparison. Results: LUS detected a progressive reduction in B-line scores in almost all patients undergoing haemodialysis, correlating with the volume of fluid removed once individuals with no or minimal B-lines upon pre-dialysis examination were discounted. When comparing CT scans pre- and post dialysis, radiologic evidence of the change in fluid status was only identified in a single patient. Conclusions: This is the first study to demonstrate that LUS detects changes in extravascular lung water caused by changing fluid status during haemodialysis using a blinded outcome assessment and that LUS appears to be more sensitive than CT for this purpose. Further research is needed to better understand the role of LUS in this and similar patient populations, with the aim of improving clinical care and outcomes.